Grove Biopharma
Signal active
Organization
Contact Information
Overview
Grove Biopharma is a biotechnology company offering a materials science solution to peptide therapeutic challenges, focused on the discovery and development of a novel class of “protein-like polymers” to treat significant unmet medical needs in chronic inflammatory and neurodegenerative diseases.
About
Industries
Biotechnology, Medical, Therapeutics
Founded
2020
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Grove Biopharma headquartered in United States, North America, operates in the Biotechnology, Medical, Therapeutics sector. The company focuses on Biotechnology and has secured $378.0M in funding across 36 round(s). With a team of 1-10 employees, Grove Biopharma is actively contributing to advancements in Biotechnology. Their latest funding round, Convertible Note - Grove Biopharma, raised $2.5M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
1
Lead Investors
0
Total Funding Amount
$10.5M
Details
2
Grove Biopharma has raised a total of $10.5M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Seed | 4.0M | ||
| 2021 | Seed | 4.0M |
Investors
Grove Biopharma is funded by 10 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| DeepWork Capital | - | FUNDING ROUND - DeepWork Capital | 4.0M |
| Grove Biopharma | - | FUNDING ROUND - Grove Biopharma | 4.0M |
| Grove Biopharma | - | FUNDING ROUND - Grove Biopharma | 2.5M |
| DeepWork Capital | - | FUNDING ROUND - DeepWork Capital | 2.5M |
Recent Activity
There is no recent news or activity for this profile.